menu
    • menu

    Company profile for Genespire

    NEW Drugs in Dev: 1
    ChemWerth works in generic API development & supply, non-infringement patent strategy development and regulatory support.

    Virtual Booth

    Contact Supplier

    Cohance Lifesciences, offers full range of CDMO services for small molecule APIs, intermediates, ADCs, Pellets and Formulations.

    Virtual Booth

    Contact Supplier

    pharmacompass-1-m-2026-01-12

    Virtual Booth

    Contact Supplier

    LEBSA- Your strategic API source for niche molecules.

    Virtual Booth

    Contact Supplier

    Mission CDMO team brings reliability, resourcefulness, & responsiveness in executing your development project.

    Virtual Booth

    Contact Supplier

    pharmacompass-2-m-2025-11-03

    Virtual Booth

    Contact Supplier

    EVENTS

    DIGITAL CONTENT

    DEVELOPMENTS

    PharmaCompass

    Only Regulatory Products (API/FDF), Drugs in Developments and News are Updated on this Virtual Booth

    Update your Virtual Booth on PharmaCompass, ask us

    About

    Genespire is a biotechnology company focused on the development of transformative gene therapies for patients affected by genetic diseases, particularly primary immunodeficiencies and inherited metabolic diseases.

    List your booth number for exhibitions, ask us

    CONTACT DETAILS

    Click the arrow to open the dropdown
    Contact SupplierContact
    Google MapGoogle Map
    Full View ScreenFull View Screen
    GenespireItaly Flag
    Country
    Country
    Italy
    Address
    Address
    Via Vincenzo Gioberti, 8 20123 Milano - Italy
    Telephone
    Telephone
    +39 02 83991300
    Client Email
    Email
    enquiries@pharmacompass.com
    Client Website
    Website
    https://www.genespire.com/
    Linkedin
    Linkedin
    youtube
    YouTube
    Twitter
    Twitter

    Upload your Marketing & Sales content on your company Virtual Booth, click HERE.

    Events

    Webinars & Exhibitions

    Request a meetingRequest a meeting
    Full Screen ViewFull Screen View
    Tides Asia

    Tides Asia

    Not Confirmed

    envelop Contact Supplier

    Tides Asia

    Post an Enquiry

    Meeting

    Digital content

    Create Content with PharmaCompass, ask us

    NEWS #PharmaBuzz

    read-more
    read-more
    Preclinical Dosing Insights for Liver Gene Therapy at ASGCT Meet
    Preclinical Dosing Insights for Liver Gene Therapy at ASGCT Meet

    14 May 2025

    // GLOBENEWSWIRE

    https://www.globenewswire.com/news-release/2025/05/14/3080807/0/en/Preclinical-insights-into-dosing-for-first-in-human-in-vivo-liver-directed-gene-therapy-for-MMA-delivered-in-an-oral-presentation-at-the-ASGCT-Annual-Meeting.html

    GLOBENEWSWIRE
    14 May 2025
    Share Share
    Genespire to present preclinical insights on liver-directed ISLV
    Genespire to present preclinical insights on liver-directed ISLV

    07 May 2025

    // GLOBENEWSWIRE

    https://www.globenewswire.com/news-release/2025/05/08/3076807/0/en/Genespire-announces-oral-presentation-at-the-ASGCT-Annual-Meeting-detailing-preclinical-insights-into-dosing-for-first-in-human-in-vivo-liver-directed-ISLV-gene-therapy-for-MMA.html

    GLOBENEWSWIRE
    07 May 2025
    Share Share
    Genespire raises 46.6M in a Series B to advance in-vivo therapy
    Genespire raises 46.6M in a Series B to advance in-vivo therapy

    24 Sep 2024

    // GLOBENEWSWIRE

    https://www.globenewswire.com/news-release/2024/09/25/2952683/0/en/Genespire-raises-46-6-million-52-million-in-a-Series-B-round-to-advance-its-first-pediatric-in-vivo-gene-therapy-into-the-clinic.html

    GLOBENEWSWIRE
    24 Sep 2024
    Share Share
    Genespire appoints Karen Aiach-Pignet as Chief Executive Officer
    Genespire appoints Karen Aiach-Pignet as Chief Executive Officer

    12 Sep 2024

    // GLOBENEWSWIRE

    https://www.globenewswire.com/news-release/2024/09/12/2945045/0/en/Genespire-appoints-Karen-Aiach-Pignet-as-Chief-Executive-Officer.html

    GLOBENEWSWIRE
    12 Sep 2024
    Share Share
    Genespire Positive Preclinical Data At ASGCT Annual Meeting
    Genespire Positive Preclinical Data At ASGCT Annual Meeting

    09 May 2024

    // GLOBENEWSWIRE

    https://www.globenewswire.com/news-release/2024/05/09/2879011/0/en/Genespire-Presents-Positive-Preclinical-Proof-of-Concept-Data-at-the-ASGCT-Annual-Meeting.html

    GLOBENEWSWIRE
    09 May 2024
    Share Share
    Genespire appoints Dr. Sabah Sallah as Chief Medical Officer
    Genespire appoints Dr. Sabah Sallah as Chief Medical Officer

    06 Jul 2022

    // GLOBENEWSWIRE

    https://www.globenewswire.com/news-release/2022/07/07/2475542/0/en/Genespire-appoints-Dr-Sabah-Sallah-as-Chief-Medical-Officer.html

    GLOBENEWSWIRE
    06 Jul 2022
    Share Share

    ABOUT THIS PAGE

    Ask Us for Pharmaceutical Supplier and Partner
    Ask Us, Find A Supplier / Partner
    No Commissions, No Strings Attached, Get Connected for FREE

    What are you looking for?

    How can we help you?

    The request can't be empty

    Please read our Privacy Policy carefully

    You must agree to the privacy policy

    The name can't be empty
    The company can't be empty.
    The email can't be empty Please enter a valid email.
    The mobile can't be empty
    • Privacy policy
    • Terms and conditions
    • Disclaimers
    • LinkedIn
    • Product listings are provided for informational purposes only. We do not supply or sell any products. Any products that may be covered by patent(s) are supplied solely for uses permitted under Section 107A of the Indian Patents Act and not for commercial sale.

    Market Place

    Market Place

    PharmaCompass

    Home

    Market Place

    Menu

    Post Enquiry

    Post Enquiry

    Market Place

    Market Place

    Search